latest news releases from the newsroom
Capital Research Group, Inc
Hot Stocks To Watch for Tuesday, October 05, 2004: CUPY, LU, SUNW, AMAT
WESTON, Fla., Oct. 5, 2004 (PRIMEZONE) -- TheSUBWAY.com names the following stocks to its Stock Watch List: CDC Systems Inc. (Pink Sheets:CUPY), Lucent Technologies (NYSE:LU), Sun Microsystems Inc. (Nasdaq:SUNW), Applied Materials Inc. (Nasdaq:AMAT).
Wall Street Capital Funding LLC
Wall Street News Alert's U.S. Hot Stock Highlights -- October 5, Part 2
WESTON, Fla., Oct. 5, 2004 (PRIMEZONE) -- Wall Street News Alert's "stocks to watch" this morning are: FTS Group, Inc. (OTCBB:FLIP), US Airways Group, Inc. (OTCBB:UAIRQ), Agere Systems, Inc. (NYSE:AGRA) and Winn-Dixie Stores, Inc. (NYSE:WIN).
FindProfit.com Provides Investment Analysis of Gaming Stocks
PRINCETON, N.J., Oct. 5, 2004 (PRIMEZONE) -- FindProfit (www.findprofit.com), an investment service that delivered a +67% audited return in 2003, announced today that it has provided to trial and paid subscribers investment analysis of gaming stocks, including coverage of Activision (NASDAQ:ATVI) and Electronic Arts (NASDAQ:ERTS).
BSD Medical Corporation
BSD Medical Corp. Sponsors Symposium and Displays Products at ASTRO
ATLANTA, Oct. 5, 2004 (PRIMEZONE) -- BSD Medical Corp. (OTCBB:BSDM) today announced that it is pursuing an aggressive agenda for the 49th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) being convened October 3-7 in Atlanta. ASTRO is the premier annual educational and scientific event for radiation oncology professionals held in the United States, and attracts about 9,000 attendees from all over the world.
Discovery Laboratories, Inc.
Discovery Laboratories Submits Marketing Authorization Application to Market Surfaxin(R)in Europe
DOYLESTOWN, Pa., Oct. 5, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that a Marketing Authorization Application (MAA) has been submitted to the European Medicines Evaluation Agency (EMEA) for clearance to market Surfaxin(R) in Europe for the treatment and prevention of Respiratory Distress Syndrome (RDS) in premature infants. Surfaxin is a novel, peptide-containing, humanized lung surfactant developed from Discovery's proprietary surfactant replacement technology platform.